Fatih Köse

[Tom Powles @tompowles1]

ADC development in urothelial cancer has led to a number of new agents (EGFR/HER2 ADCs NECTIN4/TOPO1) being explored. There has been little focus on biomarkers and more on doublets and triplets. This podcast from #UromigosLive summarised the landscape. https://t.co/I6Fl9xJIOc

[Fatih Köse @FatihKose_prof]

@ASCO @DrYukselUrun Süper!!!

[Fatih Köse @FatihKose_prof]

#esgo, #tod #zaferarık

[Fatih Köse @FatihKose_prof]

Patients with P53m advanced stage EC derive benefit even they have pMMR. ıs p53m leading IO benefit in pMMR advanced endometrial cancer patients ?

[Fatih Köse @FatihKose_prof]

atezolizumab( anti-pdl-1) also works quiet well in endometrial cancer, similar HR compared to Pembrolizumab and dostarlimab

Parp works in endometrial cancer but works for which moleküler subtype in under debate ?

[Fatih Köse @FatihKose_prof]

atezolizumab( anti-pdl-1) also works quiet well in endometrial cancer, similar HR compared to Pembrolizumab and dostarlimab

Parp works in endometrial cancer but works for which moleküler subtype in under debate ?

[Fatih Köse @FatihKose_prof]

New standard for the locally advanced cervical cancer. CCRT plus Pembrolizumab (35 weeks), provide 11.7 % addition cure rate.

[Fatih Köse @FatihKose_prof]

@DrYukselUrun @myESMO @OncoAlert @drenriquegrande @tompowles1 @DrChoueiri @OncoBellmunt @apolo_andrea @MattGalsky @sonpavde @ERPlimackMD @AndreaNecchi @gbanna74 I think after 5 years now, nobody will talk about cisplatin in first line or no body look for cisplatin or even any platin eligibility.

[TARGED @WebTarged]

Kongreden BildiriYORUM: ASCO2023
📅 07 Haziran 2023, Çarşamba
🕗19.00 - 21.20
🎯🔗 https://t.co/QdDHugMGtm
#kanser #cancer #onkoloji #oncology #tumor #tedavi #erkenteshishayatkurtarır #farkındaol #ASCO23 #asco2023 #asco23denyansıyanlar #ASCO2023akıldakalanlar

[Yüksel Ürün @DrYukselUrun]

🔬 OUTBACK trial: adjuvant carboplatin & paclitaxel chemotherapy after standard chemoradiotherapy for locally advanced cervical cancer doesn't improve 5-year survival
📉 Increased short-term toxicity but no survival benefit observed
❌ Adjuvant chemo is not recommended in this setting
-Reminder: cervical cancer is a preventable cancer with the #HPV #vaccines

#CervicalCancer #vaccineswork
@OncoAlert @OncBrothers @TheLancetOncol
https://t.co/lTs802ltQW

[Yüksel Ürün @DrYukselUrun]

🔘Switching from conventional interval dosage to extended interval dosing (ED) (pembrolizumab 400 mg Q6W or nivolumab 480 mg Q4W) of immune checkpoint inhibitors (ICI) did not increase immune-related adverse events (irAEs) in solid cancer patients.
🔘ED represents a safe option for ICI therapy. #CancerTreatment #immunotherapy @OncoAlert @sitcancer @JNCI_Now @Uromigos @ASCO @myESMO
https://t.co/xw2Cak2Tu0

[Yüksel Ürün @DrYukselUrun]

I am multitasking person!
#MedTwitter
https://t.co/sS4xSTlmNq

[TARGED @WebTarged]

Tüm Konuşmacı ve Katılımcı Hocalarımıza Teşekkür Ederiz. #webtarged

[Yüksel Ürün @DrYukselUrun]

"Sorunlarımızı onları yaratırken kullandığımız aynı düşüncelerle çözemeyiz."

"We cannot solve our problems with the same thinking we used when we created them."
-Albert Einstein

[mahirgra @mahir_gra2]

Öğrencisini taciz eden, insanlara dışkı yedirilmesini savunan herif toplumun ahlakını eleştiriyor.

Sorun ahlak sorunu değil. Sorun senin gibi bir avuç asalağın savunduğu, insanları çürük evlerde oturmaya mecbur bırakan bu düzen.

[Yüksel Ürün @DrYukselUrun]

The publication of the IMDC prognostic groups in 2009 raises the question of whether they are still relevant in the era of "contemporary" treatments.

Answer: YES! Valid thru!
@EUplatinum @OncoAlert @DrDanielHeng @DrChoueiri @DrRanaMcKay @lalaniMD @ASCO
https://t.co/e8rKeejM6I

[Yüksel Ürün @DrYukselUrun]

KN-966 Pembrolizumab+gem/cis ↗️Improved OS in Biliary Tract #Cancer
🔶There is still a lot to learn about IO. It works with gemcitabine, which is thought to be ineffective. PDL1 and TMB are helpful for some tumors or IOs but not for others??????
@OncoAlert @Merck @BusinessWire

[Yüksel Ürün @DrYukselUrun]

Adjuvant Atezo or pembro for NSCLC?
@OncoAlert @OncBrothers @IASLC
@DrChoueiri @NarjustFlorezMD @n8pennell @JackWestMD @DrJNaidoo @PatelOncology @drgandara @StephenVLiu @DrSteveMartin